prana ranked #1 lowest short interest ratio, page-5

Thanks abdm...it's easy to see why.
Fundamentally the stock shouldn't go any lower and the upside is crazy!!

Funding will see this stock fly.
Am waiting for a call back from the company to check in on progress.

Pity Brumby didn't get re-elected (not being political). That $15m would have seen us almost there.

No doubt there is some interest in PBT2 so we'll get there eventually.
I'll continue to top up at these levels.

My strategy is to keep a large core holding and do a trading parcel sell at $1. (if/when we get there)
To think PBT2 is the best performing clinical drug on Alzheimer's and possibly other diseases of similar nature we are looking at massive potential...blockbuster is the word.
Obviously a spec stock but to think the SP could be $50+ in about 6-8 years is well worth the punt.